SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Mek ICS Adds In Vitro Diagnostic Device Manufacturing to Business Scope

Mek ICS shareholders approved an amendment to the company's articles at an extraordinary meeting on Oct. 30, 2026, adding in vitro diagnostic medical-device manufacturing as a business purpose.

SquawkNews Desk

Related stories

AstraZeneca CEO Sees Over $20 Billion in Potential Sales From 2027 Trial Readouts CEO Pascal Soriot said 2027 drug trial readouts could generate over $20 billion in peak annual sales. The company also unveiled a restructuring program targeting $1.5 billion in an M impact | EQUITY | Oct 30, 2026, 11:38 AM UTC Cboe Global Markets Reports Third-Quarter Results Cboe Global Markets reported third-quarter diluted EPS of $4.08, up 43 percent. M impact | EQUITY | Oct 30, 2026, 11:33 AM UTC Hinduja Housing Finance Appoints Vivek Kannan CEO Kannan succeeds Sachin Pillai and will oversee business performance, operations, risk and growth. He previously served as the company’s chief operating officer. M impact | EQUITY | Oct 30, 2026, 11:32 AM UTC Acumen Pharmaceuticals shares fall 75% premarket Acumen Pharmaceuticals (ABOS) shares fell 75% before the market open. H impact | EQUITY | Oct 30, 2026, 11:31 AM UTC Asian Stocks Fall, Led by South Korea’s Kospi Japan’s Nikkei 225 dropped 2.1% to 63,290.11, the Topix fell 1%, South Korea’s Kospi declined around 3.5%, and mainland China’s Shanghai Composite was down 1.4%. Semiconductor manu M impact | EQUITY | Oct 30, 2026, 11:31 AM UTC Federal Realty Reports Third-Quarter Revenue of $339M M impact | EQUITY | Oct 30, 2026, 11:30 AM UTC